Takeda Pharmaceutical (TAK) Receivables - Net (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Receivables - Net of $5.8 billion for Q2 2026, up 26.89% year-over-year from $4.6 billion in Q2 2025, and up 8.42% quarter-over-quarter from $5.4 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Receivables - Net (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Receivables - Net history runs 10 years deep, the most recent figure standing at $5.8 billion for Q2 2026.
- In Q2 2026, Receivables - Net rose 26.89% year-over-year to $5.8 billion; the TTM figure through Jun 2026 stood at $5.8 billion (up 26.89% YoY), while the FY2026 annual figure was $6.5 billion, up 28.29% from the prior year.
- Receivables - Net for Q2 2026 stood at $5.8 billion, up from $5.4 billion in the prior quarter.
- The five-year high for Receivables - Net was $5.9 billion in Q2 2022, with the low at -$51.4 million in Q1 2022.
- The 5-year median for Receivables - Net is $4.8 billion (2023), against an average of $4.3 billion.
- The sharpest annual moves came in 2022 and 2025: Receivables - Net tumbled 100.7% in 2022, then soared 16583.02% in 2025.
- Takeda Pharmaceutical's Receivables - Net stood at $5.0 billion in 2022, then dropped by 3.22% to $4.8 billion in 2023, then slipped by 3.42% to $4.7 billion in 2024, then climbed by 2.26% to $4.8 billion in 2025, then climbed by 21.98% to $5.8 billion in 2026.
- Business Quant data shows TAK's Receivables - Net at $5.8 billion in Q2 2026, $5.4 billion in Q1 2026, and $4.8 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.84 Bn |
| Jun 30, 2026 | 5.84 Bn |
| Mar 31, 2026 | 5.38 Bn |
| Mar 31, 2026 | 5.38 Bn |
| Dec 31, 2025 | 4.79 Bn |
| Dec 31, 2025 | 4.79 Bn |
| Sep 30, 2025 | 4.68 Bn |
| Sep 30, 2025 | 4.68 Bn |
| Jun 30, 2025 | 4.60 Bn |
| Jun 30, 2025 | 4.60 Bn |
| Mar 31, 2025 | 5.05 Bn |
| Mar 31, 2025 | 5.05 Bn |
| Dec 31, 2024 | 4.68 Bn |
| Dec 31, 2024 | 4.68 Bn |
| Sep 30, 2024 | 4.70 Bn |
| Sep 30, 2024 | 4.70 Bn |
| Jun 30, 2024 | 4.85 Bn |
| Jun 30, 2024 | 4.85 Bn |
| Mar 31, 2024 | -30.66 Mn |
| Mar 31, 2024 | -30.66 Mn |